BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15485791)

  • 1. [Construction of a three-dimensional human angiogenesis model in vitro for antiangiogenic drug selection].
    Li B
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1167-70. PubMed ID: 15485791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis.
    Pourgholami MH; Khachigian LM; Fahmy RG; Badar S; Wang L; Chu SW; Morris DL
    Biochem Biophys Res Commun; 2010 Jul; 397(4):729-34. PubMed ID: 20537982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cell spheroids as a versatile tool to study angiogenesis in vitro.
    Heiss M; Hellström M; Kalén M; May T; Weber H; Hecker M; Augustin HG; Korff T
    FASEB J; 2015 Jul; 29(7):3076-84. PubMed ID: 25857554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.
    Clapp C; Martial JA; Guzman RC; Rentier-Delure F; Weiner RI
    Endocrinology; 1993 Sep; 133(3):1292-9. PubMed ID: 7689950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRN-103, a novel nicotinamide derivative, inhibits VEGF-induced angiogenesis and proliferation in human umbilical vein endothelial cells.
    Choi HE; Yoo MS; Choi JH; Lee JY; Kim JH; Kim JH; Lee JK; Kim GI; Park Y; Chi YH; Paik SH; Lee JH; Lee KT
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6236-41. PubMed ID: 21963305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors.
    Fernandez-Sauze S; Delfino C; Mabrouk K; Dussert C; Chinot O; Martin PM; Grisoli F; Ouafik L; Boudouresque F
    Int J Cancer; 2004 Mar; 108(6):797-804. PubMed ID: 14712479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C and downstream signaling pathways in a three-dimensional model of phorbol ester-induced angiogenesis.
    Taylor CJ; Motamed K; Lilly B
    Angiogenesis; 2006; 9(2):39-51. PubMed ID: 16607569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description of an in vitro angiogenesis model designed to test antiangiogenic molecules.
    Vailhé B; Ronot X; Lecomte M; Wiernsperger N; Tranqui L
    Cell Biol Toxicol; 1996 Dec; 12(4-6):341-4. PubMed ID: 9034631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro screening for angiostatic potential of herbal chemicals.
    Cao L; Liu H; Lam DS; Yam GH; Pang CP
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6658-64. PubMed ID: 20671276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of triptolide on migration of vascular endothelial cells].
    Ding Y; Zhao QL; Li YG; Zhang J; Wang QL; Wang SR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):347-50. PubMed ID: 15931865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzo[a]pyrene inhibits angiogenic factors-induced alphavbeta3 integrin expression, neovasculogenesis, and angiogenesis in human umbilical vein endothelial cells.
    Li CH; Cheng YW; Hsu YT; Hsu YJ; Liao PL; Kang JJ
    Toxicol Sci; 2010 Dec; 118(2):544-53. PubMed ID: 20876236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
    Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
    Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of the angiostatic potential of drugs using an endothelialized tissue-engineered connective tissue.
    Tremblay PL; Berthod F; Germain L; Auger FA
    J Pharmacol Exp Ther; 2005 Nov; 315(2):510-6. PubMed ID: 16055674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agents.
    Zerp SF; Vink SR; Ruiter GA; Koolwijk P; Peters E; van der Luit AH; de Jong D; Budde M; Bartelink H; van Blitterswijk WJ; Verheij M
    Anticancer Drugs; 2008 Jan; 19(1):65-75. PubMed ID: 18043131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scutellarin promotes in vitro angiogenesis in human umbilical vein endothelial cells.
    Gao ZX; Huang DY; Li HX; Zhang LN; Lv YH; Cui HD; Zheng JH
    Biochem Biophys Res Commun; 2010 Sep; 400(1):151-6. PubMed ID: 20709020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth.
    Ruggeri BA; Robinson C; Angeles T; Wilkinson J; Clapper ML
    Clin Cancer Res; 2002 Jan; 8(1):267-74. PubMed ID: 11801568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.
    Tran TC; Sneed B; Haider J; Blavo D; White A; Aiyejorun T; Baranowski TC; Rubinstein AL; Doan TN; Dingledine R; Sandberg EM
    Cancer Res; 2007 Dec; 67(23):11386-92. PubMed ID: 18056466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen.
    Shekhar MP; Werdell J; Tait L
    Cancer Res; 2000 Jan; 60(2):439-49. PubMed ID: 10667599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.